Alzheimer disease-related activities in China: A report from the International Working Group on the Harmonization of Dementia Drug Guidelines

被引:1
|
作者
Doody, R
Whitehouse, PJ
Chen, QT
Wang, GN
Wu, QH
Rosser, M
Xu, XH
机构
[1] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[2] Baylor Coll Med, Alzheimer Dis Res Ctr, Houston, TX 77030 USA
[3] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA
[4] First Hosp Beijing Med Univ, Beijing, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[6] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[7] Beijing Hosp, Dept Neurol, Beijing, Peoples R China
来源
关键词
D O I
10.1097/00002093-199812000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:263 / 265
页数:3
相关论文
共 50 条
  • [1] Report of the International Working Group on Harmonization of Dementia Drug Guidelines - Introduction
    Whitehouse, PJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 1 - 1
  • [2] Harmonization of dementia drug guidelines (United States and Europe): A report of the International Working Group for the Harmonization for Dementia Drug Guidelines
    Whitehouse, PJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S119 - S122
  • [3] Prevention protocols for Alzheimer disease - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Thal, LJ
    Carta, A
    Doody, R
    Leber, P
    Mohs, R
    Schneider, L
    Shimohama, S
    Silber, C
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 46 - 49
  • [4] Alzheimer's disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia
    Brodaty, H
    Dresser, R
    Eisner, M
    Erkunjuntti, T
    Gauthier, S
    Graham, N
    Jonker, C
    Sachs, G
    Whitehouse, P
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1999, 13 (02): : 71 - 79
  • [5] Cultural issues in the clinical diagnosis of Alzheimer disease - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Amaducci, L
    Baldereschi, M
    Doody, R
    Chandra, V
    Gaines, AD
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 19 - 21
  • [6] Protocols to demonstrate slowing of Alzheimer disease progression - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Bodick, N
    Forette, F
    Hadler, D
    Harvey, RJ
    Leber, P
    McKeith, IG
    Riekkinen, PJ
    Rossor, MN
    Scheltens, P
    Shimohama, S
    Spiegel, R
    Tanaka, S
    Thal, LJ
    Urata, Y
    Whitehouse, P
    Wilcock, G
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 50 - 53
  • [7] Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines
    Harvey, RJ
    Sciulli, CG
    Mason, RM
    Whitehouse, PJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 29 - 32
  • [8] The International Working Group on Harmonization of Dementia Drug Guidelines: Past, present, and future
    Whitehouse, PJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 2 - 5
  • [9] Ethical issues in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Post, SG
    Beerman, B
    Brodaty, H
    Gaines, AW
    Gauthier, SG
    Geldmacher, DS
    Hill, S
    Homma, A
    Rossor, MN
    Whitehouse, PJ
    Winblad, B
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 26 - 28
  • [10] Clinical global measures of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Reisberg, B
    Schneider, L
    Doody, R
    Anand, R
    Feldman, H
    Haraguchi, H
    Kumar, R
    Lucca, U
    Mangone, CA
    Mohr, E
    Morris, JC
    Rogers, S
    Sawada, T
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 8 - 18